09:24 AM EDT, 09/24/2025 (MT Newswires) -- Eupraxia Pharmaceuticals ( EPRX ) said Wednesday that it has closed its public offering of about 14.6 million common shares priced at $5.50 per share, with the underwriters fully exercising an option to buy additional shares.

The company said it raised about $80.5 million in gross proceeds. Net proceeds will be used for further development of its product pipeline, research and development of additional pipeline candidates, business development activities, and general corporate purposes, the company added.

Shares of Eupraxia Pharmaceuticals ( EPRX ) were up more than 12% in recent Wednesday premarket activity.